Acyclic nucleotide analogues suppress growth and induce apoptosis in human leukemia cell lines

International Journal of Oncology

Volumn 14, Issue 4, 1999, Pages 745-752

  Franek, Frantisek ^a,d   Holy, Antonín ^b   Votruba, Ivan ^b   Eckschlager, Tomás ^c  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

^c UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^d Institute of Molecular Genetics   (Czech Republic)

Author keywords

Acyclic nucleotide analogues; Apoptosis; Cell cycle perturbation; Cell growth inhibition; Human leukemia cell lines

Indexed keywords

2,6 DIAMINO 9 (2 PHOSPHONOMETHOXYETHYL)PURINE; 9 ((2 PHOSPHONYLMETHOXY)ETHYL)GUANINE; 9-((2-PHOSPHONYLMETHOXY)ETHYL)GUANINE; 9-(2-PHOSPHONYLMETHOXYETHYL)-2,6-DIAMINOPURINE; ADENINE; ANTINEOPLASTIC AGENT; DNA; DRUG DERIVATIVE; GUANINE; ORGANOPHOSPHORUS COMPOUND;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIVISION; CELL STRAIN HL 60; DRUG EFFECT; DRUG SCREENING; HUMAN; MYELOID LEUKEMIA; PATHOLOGY; PHYSIOLOGY;

ADENINE; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL DIVISION; DNA, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; GUANINE; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; ORGANOPHOSPHORUS COMPOUNDS; TUMOR CELLS, CULTURED;

EID: 0033110129     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.4.745     Document Type: Article

References (43)

1. Holy A: Isopolar phosphorus-modified nucleotide analogues. In: Advances in Antiviral Drug Design. Vol. 1. De Clercq E (ed). JAI Press Inc., Greenwich, CT, pp179-232, 1994.
2. Cundy KC, Barditch-Crovo P, Walker RE, Collier AC, Ebeling D, Toole J and Jaffe HS: Clinical pharmacokinetics of adefovir in human immunodeficiency virus type 1-infected patients. Antimicrob Agents Chemother 39: 2401-2405, 1995.
3. Vesely J, Merta A, Votruba I, Holy A and Rosenberg I: The cytostatic effects and mechanism of action of antiviral acyclic nucleotide analogues in L1210 mouse leukemia cells. Neoplasma 37: 105-110, 1990.
4. Otová B, Zidek Z, Holy A, Votruba I, Sladká M, Marinov I and Lesková V: Antitumor activity of novel purine acyclic nucleotide analogs PMEA and PMEDAP. In Vivo 11: 163-168, 1997.
5. Otová B, Sladká M, Votruba I, Holy A and Kren V: Cytostatic effect of 9-(2-phosphonomethoxyethyl)adenine (PMEA). I. Lymphatic leukemia KHP-Lw-1 in Lewis rats. Folia Biol 39: 136-141, 1993.
6. Otová B, Sladká M, Blazek K, Schramlová J, Votruba I and Holy A: Cytostatic effect of 9-(2- phosphonomethoxyethyl)adenine (PMEA). II. Lymphoblastic leukemia in Sprague-Dawley rats. Folia Biol 39: 142-149, 1993.
7. Otová B, Krenová D, Zidek Z, Holy A, Votruba I and Kren V: Cytostatic effect of 9-(2-phosphonomethoxyethyl)adenine (PMEA). III.-Rat and mouse carcinomas and sarcomas. Folia Biol 40: 185-192, 1993.
8. Rose WC, Crosswell AR, Bronson JJ and Martin JC: In vivo antitumor activity of 9-[(2-phosphonylmethoxy)ethyl]guanine and related phosphonate nucleotide analogues. J Natl Cancer Inst 82: 510-512, 1990.
9. Neyts J, Sadler R, De Clercq E, Raab-Traub N and Pagano JS: The antiviral agent cidofovir [(S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine] has pronounced activity against nasopharyngcal carcinoma grown in nude mice. Cancer Res 58: 384-388, 1998.
10. Kramata P, Votruba I, Otova B and Holy A: Different inhibitory potencies of acyclic phosphonomethoyalkyl nucleotide analogs toward DNA polymerases, δ and ε. Mol Pharmacol 49: 1005-1011, 1996.
11. Merta A, Vesely J, Votruba I, Rosenberg I and Holy A: Phosphorylation of acyclic nucleotide analogues HPMPA and PMEA in L-1210 mouse leukemic cell extracts. Neoplasma 37: 111-120, 1990.
12. Cherrington JM, Allen SJW, Bischofberger N and Chen MS: Kinetic interaction of the diphosphates of 9-(2-phosphonomethoxyethyl)adenine and ither anti-HIV active purine congeners with HIV reverse transcriptase and human DNA polymerases alpha, beta and gamma. Antivir Chem Chemother 6: 217-221, 1995.
13. Cerny J, Votruba I, Vonka V, Rosenberg I, Otmar M and Holy A: Phosphonylmethylethers of acyclic nucleoside analogues: inhibitors of HSV-1 induced ribonucleotide reductase. Antiviral Res 13: 253-264, 1990.
14. Cihlár T, Rosenberg I, Votruba I and Holy A: Transport of 9-(2-phosphonomethoxyethyl)adenine across plasma membrane of HeLa S3 cells is protein mediated. Antimicrob Agents Chemother 39: 117-124, 1995.
15. Franck F and Srámková K: Protection of B lymphocyte hybridoma against starvation-induced apoptosis: survival-signal role of some amino acids. Immunol Lett 52: 139-144, 1996.
16. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 252: 2680-2683, 1983.
17. Franck F: Starvation-induced programmed death of hybridoma cells: prevention by amino acid mixtures. Biotechnol Bioeng 45: 86-90, 1995.
18. Roselli F, Ridet A, Soussi T, Duchaud E, Alapetite C and Moustachi E: p53-dependent pathway of radio-induced apoptosis is altered in Fanconi anemia. Oncogene 10: 9-17, 1995.
19. Robinson JP (ed): Handbook of Flow Cytometry Methods. J Wiley and Sons, New York, 1993.
20. Holy A, Rosenberg I and Dvoráková H: Synthesis of N-(2-phosphonylmethoxyethyl)derivatives of heterocyclic bases. Collect Czech Chem Commun 54: 2190-2210, 1989.
21. Otova B, Holy A, Votruba I, Sladká M, Bílá V, Mejsnarová B and Lesková V: Genotoxicity of purine acyclic nucleotide analogs. Folia Biol 43: 225-229, 1997.
22. Krejcová R, Horská K, Votruba I and Holy A: Phosphorylation of phosphonomethoxyalkylguanines by GMP-kinase isoenzymes. Collect Czech Chem Commun 61: 188-191, 1996.
23. Del Bino G, Skierski JS and Darzynkiewicz Z: Diverse effects of camptothecin, an inhibitor of topoisomerase I, on the cell cycle of lymphocytic (L1210, MOLT-4) and myelogenous (HL- 60, KG1) leukemic cells. Cancer Res 50: 5746-5750, 1990.
24. Del Bino G and Darzynkiewicz Z: Camptothecin, teniposide, or 4′-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxanthrone or doxorubicin, induces degradation of nuclear DNA in the S phase of HL-60 cells. Cancer Res 51: 1165-1169, 1991.
25. Gorczyca W, Gong J, Ardelt B, Traganos F and Darzynkiewicz Z: The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res 53: 3186-3192, 1993.
26. Traganos F, Ardelt B, Halko N, Bruno S and Darzynkiewicz Z: Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 leukemic cells. Cancer Res 52: 6200-6208, 1992.
27. Kastan MB, Onyekwere O, Sidransky D, Vogelstein B and Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51: 6304-6311, 1991.
28. Lowe SW, Ruley HE, Jacks T and Housman DE: p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967, 1993.
29. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88: 323-331, 1997.
30. Mercer WE, Shields MT, Amin M, Sauve GJ, Appella E, Romano JW and Ullrich SJ: Negative growth regulation in a glioblastoma tumor cell line that conditionally express human wild-type p53. Proc Natl Acad Sci USA 87: 6166-6170, 1990.
31. Lane DP: p53, guardian of the genome. Nature 358: 15-16, 1992.
32. Hartwell LH and Kastan MB: Cell cycle control and cancer. Science 266: 1821-1828, 1994.
33. Stewart N, Hicks GG, Paraskevas F and Mowat M: Evidence for a second cell block at G2/M by p53. Oncogene 10: 109-115, 1995.
34. Guillouf C, Rosselli F, Krishnaraju K, Moustacchi E, Hoffman B and Liebermann DA: p53 involvement in control of G2 exit of the cell cycle: role in DNA damage-induced apoptosis. Oncogene 10: 2263-2270, 1995.
35. Nakano H, Kurihara K, Okamoto M, Toné S and Shinohara K: Heat-induced apoptosis and p53 in cultured mammalian cells. Int J Radiat Biol 71: 519-529, 1997.
36. Strasser A, Harris AW, Jacks T and Cory S: DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanism inhibitable by Bcl-2. Cell 79: 329-339, 1994.
37. Del Bino G, Skierski J and Darzynkiewicz Z: The concentration-dependent diversity of effects of DNA topoisomerase I and II inhibitors on the cell cycle of HL-60 cells. Exp Cell Res 195: 485-491, 1991.
38. Yin DX and Schimke RT: BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res 55: 4922-4928, 1995.
39. Merritt AJ, Allen TD, Potten CS and Hickman JA: Apoptosis in small intestinal epithelia from p53-null mice: evidence for delayed, p53-independent G2/M-associated cell death after gamma-irradiation. Oncogene 14: 2759-2766, 1997.
40. Novick A and Szilard L: Description of the chemostat. Science 112: 715-718, 1950.
41. Franck F and Srámková K: Cell suicide in starving hybridoma culture: survival-signal effect of some amino acids. Cytotechnology 21: 81-89, 1996.
42. Hickman JA: Apoptosis and chemotherapy resistence. Eur J Cancer 32A: 921-926, 1996.
43. Boyle CC and Hickman JA: Toxin-induced increase in survival factor receptors: modulation of the threshold for apoptosis. Cancer Res 57: 2404-2409, 1997.